Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of golimumab for steroid-dependent ulcerative colitis
2014-002579-27Phase 4Completed
- Sponsor
- Humanitas Research Hospital
- Start
- Jan 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of golimumab in autoimmune colitis, sponsored by Humanitas Research Hospital. Primary endpoint: Steroid-free clinical and endoscopic remission at week 16. Started Jan 2015; status: completed.
02
Drugs
golimumab
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2014-002579-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002579-27.